Browse result page of CancerPDF Database
Please click on CancerPDF_ID for detailed information about peptide.
| CancerPDF_ID | Peptide seq | Protein Name | Fluid | Mass/Z | Profiling Technique | Cancer Type | Expression Regulation | PUBMED ID |
|---|---|---|---|---|---|---|---|---|
| CancerPDF_ID2174 | NFPSPVDAAF | Hemopexin precursor (Beta-1B-glycoprotein) | Serum | 1063.49746 | LC-MS | Colorectal cancer | NA | 21136997 |
| CancerPDF_ID2175 | NFPSPVDAAFR | Hemopexin precursor (Beta-1B-glycoprotein) | Serum | 1219.59857 | LC-MS | Colorectal cancer | NA | 21136997 |
| CancerPDF_ID3051 | VWVYPPEK | Hemopexin | Plasma | 1016.5331 | LC-MS | Normal | NA | 21136997 |
| CancerPDF_ID3052 | NFPSPVDAAF | Hemopexin | Plasma | 1063.4975 | LC-MS | Normal | NA | 21136997 |
| CancerPDF_ID3053 | KNFPSPVDAAF | Hemopexin | Plasma | 1191.5924 | LC-MS | Normal | NA | 21136997 |
| CancerPDF_ID3054 | WDRELISER | Hemopexin | Plasma | 1202.6044 | LC-MS | Normal | NA | 21136997 |
| CancerPDF_ID3055 | DRELISERW | Hemopexin | Plasma | 1202.6044 | LC-MS | Normal | NA | 21136997 |
| CancerPDF_ID3056 | NFPSPVDAAFR | Hemopexin | Plasma | 1219.5986 | LC-MS | Normal | NA | 21136997 |
| CancerPDF_ID3057 | HNSVFLIKGDK | Hemopexin | Plasma | 1256.6877 | LC-MS | Normal | NA | 21136997 |
| CancerPDF_ID3058 | GDKVWVYPPEK | Hemopexin | Plasma | 1316.6765 | LC-MS | Normal | NA | 21136997 |
| CancerPDF_ID3059 | KWDRELISER | Hemopexin | Plasma | 1330.6994 | LC-MS | Normal | NA | 21136997 |
| CancerPDF_ID3060 | WKNFPSPVDAAF | Hemopexin | Plasma | 1377.6717 | LC-MS | Normal | NA | 21136997 |
| CancerPDF_ID3061 | WDRELISERW | Hemopexin | Plasma | 1388.6837 | LC-MS | Normal | NA | 21136997 |
| CancerPDF_ID3062 | QGHNSVFLIKGDK | Hemopexin | Plasma | 1441.7678 | LC-MS | Normal | NA | 21136997 |
| CancerPDF_ID3063 | KWDRELISERW | Hemopexin | Plasma | 1516.7787 | LC-MS | Normal | NA | 21136997 |
| CancerPDF_ID3064 | WKNFPSPVDAAFR | Hemopexin | Plasma | 1533.7728 | LC-MS | Normal | NA | 21136997 |
| CancerPDF_ID3065 | SHKWDRELISER | Hemopexin | Plasma | 1554.7903 | LC-MS | Normal | NA | 21136997 |
| CancerPDF_ID3066 | HKWDRELISERW | Hemopexin | Plasma | 1653.8376 | LC-MS | Normal | NA | 21136997 |
| CancerPDF_ID3067 | NFPSPVDAAFRQGHN | Hemopexin | Plasma | 1655.7804 | LC-MS | Normal | NA | 21136997 |
| CancerPDF_ID3068 | SHKWDRELISERW | Hemopexin | Plasma | 1740.8696 | LC-MS | Normal | NA | 21136997 |
| CancerPDF_ID3069 | SGAQATWTELPWPHEK | Hemopexin | Plasma | 1836.8795 | LC-MS | Normal | NA | 21136997 |
| CancerPDF_ID3070 | SHKWDRELISERWK | Hemopexin | Plasma | 1868.9646 | LC-MS | Normal | NA | 21136997 |
| CancerPDF_ID3071 | PPTSAHGNVAEGETKPDPDVTER | Hemopexin | Plasma | 2403.1302 | LC-MS | Normal | NA | 21136997 |
| CancerPDF_ID3072 | QGHNSVFLIKGDKVWVYPPEK | Hemopexin | Plasma | 2440.2903 | LC-MS | Normal | NA | 21136997 |
| CancerPDF_ID4198 | AHQWPQGPSAV | Hemopexin | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID4577 | DGALCMEKSLGPNSCSANGPGLYLI | Hemopexin | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID4833 | FFQGDREW | Hemopexin | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID5004 | FQGDREWF | Hemopexin | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID5008 | FQGNQFLRFDPV | Hemopexin | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID5769 | LFFQGDREWF | Hemopexin | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID5925 | LLQDEFPGIPSPLDAAVECH | Hemopexin | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID7561 | TSDNHGATYAFSGTHY | Hemopexin | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID8101 | VWKSHKWDRELI | Hemopexin | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID8140 | WKNFPSPVD | Hemopexin | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID10014 | AFRQGHNSVF | Hemopexin | Urine | 1162.5769 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10037 | AAFRQGHNSVF | Hemopexin | Urine | 1233.6132 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10101 | VWKSHKWDRE | Hemopexin | Urine | 1370.6835 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10154 | VWKSHKWDREL | Hemopexin | Urine | 1483.738 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10245 | ISERWKNFPSPVDA | Hemopexin | Urine | 1645.8522 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10503 | VSGYPKRLEKEVGTPHGIIL | Hemopexin | Urine | 2193.2343 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10579 | SALTSDNHGATYAFSGTHYWRL | Hemopexin | Urine | 2455.1245 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10739 | FFKGEF | Hemopexin | Urine | 774.387 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID11570 | HGNVAEGETKPD | Hemopexin | Serum | 1252.5684 | LC-MS | Melanoma | "Present in 8 cancer samples out of 8 cancer samples. ,Present in 4 healthy samples out of 4 healthy samples." | 26992070 |
| CancerPDF_ID12138 | SAHGNVAEGETKPD | Hemopexin | Serum | 1410.6375 | LC-MS | Melanoma | "Present in 8 cancer samples out of 8 cancer samples. ,Present in 4 healthy samples out of 4 healthy samples." | 26992070 |
| CancerPDF_ID12457 | TPLPPTSAHGNVAEGETKPD | Hemopexin | Serum | NA | LC-MS | Melanoma | "Present in 7 cancer samples out of 8 cancer samples. ,Present in 4 healthy samples out of 4 healthy samples." | 26992070 |
| CancerPDF_ID12482 | TSAHGNVAEGETKPD | Hemopexin | Serum | 1511.6852 | LC-MS | Melanoma | "Present in 8 cancer samples out of 8 cancer samples. ,Present in 4 healthy samples out of 4 healthy samples." | 26992070 |
| CancerPDF_ID12483 | TSAHGNVAEGETKPDPD | Hemopexin | Serum | 1723.7649 | LC-MS | Melanoma | "Present in 8 cancer samples out of 8 cancer samples. ,Present in 4 healthy samples out of 4 healthy samples." | 26992070 |
| CancerPDF_ID13913 | HGNVAEGETKPD | Hemopexin | Plasma | 1253.576 | ?LC-MS | "Multiple myeloma patients, Acute myeloid leukemia" | NA | 20974924 |
| CancerPDF_ID13914 | HGNVAEGETKPD | Hemopexin | Plasma | 1253.576 | ?LC-MS | "Multiple myeloma patients, Acute myeloid leukemia" | NA | 20974924 |
| CancerPDF_ID13933 | VAEGETKPD | Hemopexin | Plasma | 945.453 | ?LC-MS | "Multiple myeloma patients, Acute myeloid leukemia" | NA | 20974924 |